Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psyllium for Niacin Flushing
NCT03370848Phase 4Completed
- Sponsor
- VA Greater Los Angeles Healthcare System
- Start
- Mar 2009
- Primary completion
- Jul 2011
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by VA Greater Los Angeles Healthcare System. Primary endpoint: Global Flushing Severity Score up to 6 weeks. Started Mar 2009; status: completed.
Beyond the preview
Go deeper on NCT03370848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03370848.